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Cardiovascular Research Center, Division of Cardiology, Mount Sinai School of Medicine, New York, New YorkABSTRACT Chronically elevated levels of oxidative stress resulting from increased production and/or impaired scavenging of
reactive oxygen species are a hallmark of mitochondrial dysfunction in left ventricular hypertrophy. Recently, oscillations of the
mitochondrial membrane potential (DJm) were mechanistically linked to changes in cellular excitability under conditions of acute
oxidative stress produced by laser-induced photooxidation of cardiac myocytes in vitro. Here, we investigate the spatiotemporal
dynamics of DJm within the intact heart during ischemia-reperfusion injury. We hypothesize that altered metabolic properties in
left ventricular hypertrophy modulate DJm spatiotemporal properties and arrhythmia propensity.INTRODUCTIONLeft ventricular hypertrophy (LVH) in response to elevated
systemic pressure forms an adaptive and reversible mecha-
nism that allows the heart to maintain cardiac output in the
face of external stress. However, because LVH is associated
with complex electrophysiological, structural, molecular,
mechanical, and metabolic remodeling, it ultimately
becomes a leading risk factor for heart failure, myocardial
infarction, and ventricular arrhythmias (1).
Changes in mitochondrial energetics are a hallmark of
hypertrophied and failing hearts (2–6). Numerous studies
have shown that mitochondria are indeed central to the path-
ophysiology of the hypertrophied heart. For example,
a marked shift in substrate utilization (free fatty acid to
glucose) for energy production has been documented in
various animal models and humans with hypertrophy (7).
In addition, LVH is associated with mitochondrial structural
deformities (8), including increased mitochondrial volume
and disrupted mitochondrial network architecture. These
fundamental changes, which alter the intricate regulation of
myocardial bioenergetics, disrupt the balance between pro-
and antioxidant pathways, and promote the activation of
cell death pathways, contribute significantly to the progres-
sion of cardiac dysfunction and remodeling.
The mitochondrial membrane potential (DJm) is a key
indicator of cellular viability because it reflects the capacity
of the electron transport chain to pump hydrogen ions across
the inner membrane, a requirement for oxidative phosphory-
lation and ATP generation (9,10). Chronic alterations in
DJm in various metabolic disorders cause cell death.
Dynamic oscillations of DJm produced by artificial condi-
tions of oxidative stress in isolated cardiac myocytes can
result in metabolic and electrophysiological oscillationsSubmitted November 23, 2009, and accepted for publication January 19,
2010.
6Hongwei Jin and Robert D. Nass contributed equally to this work.
*Correspondence: fadi.akar@mssm.edu
Editor: Michael D. Stern.
 2010 by the Biophysical Society
0006-3495/10/05/2063/9 $2.00that significantly impact myocyte function and lead to inex-
citability at the cellular level by activating ATP-sensitive
potassium channels (11–13). Furthermore, stabilization of
DJm using pharmacological interventions that inhibit the
mitochondrial benzodiazepine receptor can lead to action
potential (AP) stabilization and prevention of arrhythmias in
ex vivo perfused hearts subjected to ischemia-reperfusion
(IR) injury (11,14). As such, changes in DJm are thought to
modulate cellular electrophysiological changes that can scale
to the level of the intact organ and affect excitability and
arrhythmia propensity via a mechanism that Akar et al. (11)
termed metabolic sink/block.
Despite correlative findings linking interventions that alter
mitochondrial function in vitro to functional changes in vivo,
a direct investigation of dynamic changes in DJm at the
level of the intact organ remains lacking because of technical
challenges in measuring the spatiotemporal kinetics of DJm
across the intact heart. In this work, we developed a novel (to
our knowledge), quantitative imaging technique for measur-
ing the spatiotemporal dynamics of DJm with subcellular
resolution at the organ level. We then assessed dynamic
changes in DJm gradients during IR injury in normal and
chronically diseased LVH hearts.MATERIALS AND METHODS
Pressure overload hypertrophy model
All procedures involving the handling of animals were approved by the
Animal Care and Use Committee of the Mount Sinai School of Medicine
and adhered to the Guide for the Care and Use of Laboratory Animals pub-
lished by the National Institutes of Health. As previously described in detail
(15,16), pressure overload LVH was produced in male Sprague-Dawley rats
(200–250 g) by ascending aortic banding. Briefly, 14 male rats underwent
a right lateral thoracotomy to allow the placement of a 1-mm-diameter
metallic clip around the ascending aorta. The animals were allowed to
survive for 1 month after the procedure, which established an artificial aortic
stenosis. We recently characterized the electrophysiological, mechanical,
and structural changes that develop in this model of concentric hypertrophy
(15). Thirteen normal rat hearts served as the control group.doi: 10.1016/j.bpj.2010.01.045
2064 Jin et al.Echocardiographic measurements
Echocardiography was performed under ketamine sedation (intraperitoneal,
60–100 mg/kg). Long- and short-axis views were obtained using a 14 MHz
GE-i13L probe as recommended by the American Society of Echocardiog-
raphy. Short-axis views were obtained as transverse sections of the LV at the
mid-papillary level, and echocardiographic windows were selected to obtain
circular images. The transducer position was carefully adjusted until the short-
axis image of the LV cavity appeared to be circular, indicating perpendicular
intersection of the LV by the ultrasonic beam. A 12MHz GE-10S probe was
used to obtain apical four-chamber views. LV wall thickness and cavity
dimensions were measured in systole and diastole with M-mode echocardiog-
raphy. Additional measurements of the LV end-diastolic volume (EDV), end-
systolic volume (ESV), stroke volume (SV), ejection fraction (EF), and heart
rate (HR) were also performed in all animals at baseline and after 4 weeks
(time of sacrifice) of aortic banding or sham operation.
High-resolution optical DJm imaging in ex vivo
perfused rat hearts
The animals (n¼ 27) were anesthetized with pentobarbital sodium (30 mg/kg,
IP). Their hearts were rapidly excised, washed with ice-cold cardioplegic
solution, transferred to a Langendorff apparatus, and retrogradely perfused
through the aorta with oxygenated (95% O2/5% CO2) Tyrodes solution con-
taining (in mM) NaCl 121.7, NaHCO3 25, KCl 4.81, MgSO4 2.74, CaCl2 2.5,
and dextrose 5.0, pH¼ 7.40, at a temperature of 365 1C. Perfusion pressure
was maintained at ~60 mmHg by adjusting perfusion flow. Volume-con-
ducted electrocardiograms were recorded for rhythm analysis and arrhythmia
scoring using noncontact silver electrodes (Grass Instruments) placed within
the chamber. ECG signals, which were recorded continuously throughout the
entire ex vivo perfusion protocol, were amplified (ECG100-MP150 amplifier;
Biopac Systems, Goleta, CA) and displayed in real time using the AcqKnowl-
edge 3.9 software package (Biopac Systems). The hearts were positioned such
that the mapping field was centered over a 4 4 mm region of LV epicardium,
midway between the apex and base (Fig. 1 A). These preparations remained
stable for>4 h of perfusion. The ex vivo experimental protocol was typically
completed in <2 h.
We developed a novel (to our knowledge), semiquantitative imaging tech-
nique of optical DJm mapping in ex vivo perfused guinea pig (17) and rat
(18,19) hearts using the DJm-sensitive dye TMRM. This method allows
mitochondrial function to be assessed at a subcellular resolution within the
intact organ (18,19). Briefly, after cannulation, the animals’ hearts were al-
lowed to stabilize for 20 min at physiological temperature (36 5 1C).
They were then stained with TMRM (250 nM; Molecular Probes) mixed in
a 500 mL volume of Tyrodes solution (dye-loading phase) for 20 min. This
was followed by a 20–30 min dye washout phase during which perfusion
was switched back to dye-free Tyrodes solution. TMRM background fluores-
cence intensity was measured periodically (in 1 min intervals) throughout the
dye-staining and washout phases using a 6400 pixel CCD-based optical
imaging approach that allowed the measurement of normalized DJm with
subcellular resolution (50mm) over a 4  4 mm window of the epicardial
surface. To measure TMRM background fluorescence, the hearts were
excited with filtered light (525 5 20 nm) emitted from a quartz tungsten
halogen lamp (Newport Corp., Goleta, CA). Emitted fluorescence was filtered
(5855 20 nm for TMRM) and focused onto the high-resolution CCD camera
(Scimeasure, Decatur, GA). Background fluorescence intensity was
measured as the amplitude difference before and after excitation (Fig. 1 A).
During the dye-loading procedure, a marked rise in background fluores-
cence was verified for multiple pixels to confirm adequate dye staining of
the heart (Fig. 1 A). During dye washout, the stability of TMRM background
fluorescence was evaluated from multiple pixels in real time, as this baseline
level served for normalization purposes during the IR protocol. In all exper-
iments, the dye washout phase was associated with stable signal intensity,
which was required to normalize subsequent changes in TMRM fluorescence
caused by IR injury. In preliminary experiments, we ensured the stability of
background fluorescence for >3 h of steady-state perfusion (Fig. 1 A).Biophysical Journal 98(10) 2063–2071High-throughput analysis of optical signals was performed using the
CardioPlex software v.8.3.3 (RedShirt Imaging, Decatur, GA). The peak
emitted TMRM fluorescence signal from each of 6400 pixels was measured
before and after excitation achieved by a computer-automated filter shutter
switch. TMRM background fluorescence was baseline corrected by subtract-
ing fluorescence levels before dye staining (<0.1%) for each pixel. Back-
ground-corrected TMRM fluorescence (DJm) during the IR protocol was
then normalized to the value of steady-state TMRM fluorescence achieved
during the dye washout phase for each of the 6400 individual pixels.
NormalizedDJm measurements during IR injury across the imaged 4 4
mm region of the heart were plotted as contour maps using Delta Graph 5.6
(Red Rock Software, Salt Lake City, UT). These maps served to illustrate the
dynamic changes in the spatial distribution of DJm.
IR injury in normal and hypertrophied hearts
IR injury promotes mitochondrial dysfunction and oxidative stress
(13,20,21). Therefore, we used a protocol of global no-flow ischemia (for
7 min), followed by reperfusion in normal and LVH hearts. In preliminary
experiments, we determined that this moderate protocol (i.e., 7 min of
ischemia) produced sustained reperfusion arrhythmias in <50% of control
hearts. Therefore, this protocol allowed us to determine whether LVH was
associated with a heightened susceptibility to IR-mediated arrhythmias.
DJm recordings were performed in 10-s intervals throughout the first
minute of reperfusion, when rapid changes were most likely to occur, and
at 1-min intervals throughout the remaining time.
The propensity for spontaneous arrhythmias was scored according to the
guideline described by Walker et al. (22) using the Lambeth Conventions.
Briefly, the following criteria were used to generate an arrhythmia score
(AS) for each unpaced control and LVH heart: 0 ¼ <50 ventricular prema-
ture beats; 1 ¼ 50–499 ventricular premature beats; 2 ¼ >500 ventricular
premature beats and/or one episode of spontaneously reverting VT/VF;
3 ¼ more than one episode of spontaneously reverting VT/VF (<1 min total
combined duration); 4¼ 1–2 min of total combined VT/VF; and 5¼>2 min
of VT/VF. AS was measured during ischemia and reperfusion in all normal
and LVH hearts.
In addition, we used a series of control (n ¼ 4) and LVH (n ¼ 4) animals
to investigate potential differences in the incidence of complex arrhythmias
(VT/VF, AS R 3) occurring in hearts that had undergone ex vivo steady-
state pacing (4 Hz) during IR injury.RESULTS
Structural, mechanical, and electrophysiological
remodeling in LVH
Four weeks of pressure overload led to marked changes in
structural and functional parameters (Fig. 1 B and Table 1),
consistent with concentric LVH. Shown in Fig. 1 B are repre-
sentative echocardiograms (right) and hematoxylin and
eosin (H&E)-stained histological cross sections (left) from
representative sham-operated and LVH animals, indicating
the presence of marked concentric hypertrophy in banded
animals. As shown in Table 1, standard metrics of wall thick-
ness measured in systole (interventricular septal width in
systole (IVSs) and left ventricular posterior wall in systole
(LVPWs)) and diastole (interventricular septal width in dias-
tole (IVSd) and left ventricular posterior wall in diastole
(LVPWd)) were significantly (p < 0.001) increased by
50–75% over baseline values. Fractional shortening (FS)
increased by 29% (p < 0.001), whereas ESV decreased by
67% (p < 0.001). HR, SV, and cardiac output remained
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FIGURE 1 (A) Three representative traces (A–C) from
a total of 6400 pixels are shown indicating the measure-
ment of background fluorescence used to monitor relative
changes in DJm. Also shown is the background fluores-
cence during and after (for up to 300 min) the dye-loading
and washout procedures. These data demonstrate the
stability of TMRM fluorescence during steady-state perfu-
sion. The steady-state level of TMRM fluorescence for
each pixel is used for normalization purposes. (B) Repre-
sentative ECG images of a sham-operated and an aortic-
banded LVH heart. H&E-stained histological sections
from sham-operated and LVH hearts indicate marked
concentric hypertrophy in aortic banded animals. Also
shown are representative optical AP traces measured in
representative di-4-ANEPPS-stained normal and LVH
hearts during steady-state pacing.
Spatiotemporal Dynamics of DJm in Hypertrophy 2065stable. Also consistent with hypertrophic remodeling, optical
AP mapping in a subset of di-4-ANEPPS-stained control
(n ¼ 4) and LVH (n ¼ 4) hearts revealed a significant
increase in APD in LVH. Representative AP traces from
control (black) and LVH (red) hearts during steady-state
pacing are shown in Fig. 1 B (left).Metabolic remodeling in LVH: paradoxical stability
of DJm during ischemia
As shown in Fig. 2 A, ischemia caused a rapid and sustained
decline (depolarization) of normalizedDJm in control hearts.
Within 1 min of ischemia, normalized DJm was reduced by
26% compared to preischemic baseline levels. DJm was
further decreased to ~50% of baseline by 4 min of ischemiaand was sustained at that level throughout the remaining
ischemic episode. Of interest, reperfusion led to a rapid and
sustained repolarization of DJm. In a subset of studies, we
found that reperfusion after longer (15 min) episodes of
ischemia could only transiently repolarize DJm (not shown)
(19). Since these hearts exhibited reperfusion VF in almost
all cases, we chose a milder IR injury protocol to study poten-
tial differences between control and LVH hearts.
In sharp contrast, LVH hearts were resistant to ischemia-
induced DJm depolarization (Fig. 2 A, black symbols). On
average, DJm was significantly increased (by 17%, p ¼
0.0082) rather than decreased during ischemia compared to
baseline levels (Fig. 2 A). Furthermore, the paradoxical
increase in DJm observed during ischemia was sustained
after reperfusion in LVH (Fig. 2 A). The marked differencesBiophysical Journal 98(10) 2063–2071
TABLE 1 Results of statistical analyses of structural and
mechanical indices of echocardiographic measurements at
baseline and after 4 weeks of LVH
Preoperative
1 Month
postoperative
%
Change
Paired
t-testMean SD Mean SD
HR (bpm) 427.29 55.90 395.44 36.36 6.25 p ¼ 0.0694
IVSD (cm)* 0.17 0.02 0.29 0.04 75.95 p < 0.0001
IVSS (cm)* 0.32 0.03 0.52 0.04 63.86 p < 0.0001
LVIDd (cm) 0.63 0.05 0.64 0.10 0.82 p ¼ 0.82
LVIDs (cm)* 0.26 0.05 0.16 0.08 40.23 p < 0.0001
LVPWd (cm)* 0.18 0.05 0.29 0.04 64.07 p < 0.0001
LVPWs (cm)* 0.32 0.04 0.48 0.08 49.55 p < 0.0001
EDV (mL) 0.60 0.13 0.64 0.25 5.21 p ¼ 0.39
ESV (mL)* 0.05 0.03 0.02 0.02 67.40 p < 0.0001
EF (%)* 91.75 3.30 97.62 2.07 6.50 p < 0.0001
SV (mL) 0.54 0.11 0.62 0.25 12.45 p ¼ 0.15
FS (%)* 59.04 5.91 76.02 10.19 29.83 p ¼ 0.0002
CO (mL/min) 427.29 55.90 395.44 36.36 6.25 p ¼ 0.64
LVIDd: left ventricular internal dimension in diastole; LVIDs: left ventric-
ular internal dimension in systole.
*Indicates statistical significance p < 0.05.
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FIGURE 2 (A) Average and SD of DJm response to IR injury in normal
and LVH hearts. Clearly, LVH prevents ischemia-induced depolarization
of DJm. (B) Average DJm response during the entire episode of ischemia
(over 7 min) and reperfusion in normal and LVH hearts. LVH is associated
with a significantly more polarized DJm during both ischemia and re-
perfusion.
2066 Jin et al.in average DJm between control and LVH hearts during
ischemia and reperfusion are also quantified in Fig. 2 B.
Clearly, average normalized DJm was significantly (p <
0.001) greater during both ischemia and reperfusion
compared to control hearts.
In addition to the average DJm, we measured the spatio-
temporal patterns of DJm during ischemia and reperfusion.
Shown in Fig. 3 are contour maps recorded at various time
points during the course of ischemia (top row) and reperfu-
sion (bottom row) in control (Fig. 3 A) and LVH (Fig. 3 B)
hearts. It is evident that ischemia led to a rapid (within 1 min)
depolarization of DJm in the control heart. Of interest, these
contour maps reveal the formation of an organized wavefront
of DJm depolarization that actively propagated during the
course of ischemia (arrow) across the control heart. As men-
tioned above, reperfusion led to a rapid and sustained repo-
larization of DJm across the entire mapping field. Although
on average, DJm failed to depolarize during ischemia in
LVH, an examination of the spatiotemporal changes in
DJm revealed the presence of complex neighboring regions
of increased (green) and decreased (red) DJm. These
regions of opposite DJm polarity compared to baseline
were relatively static and did not exhibit major fluctuations
throughout the entire ischemic episode (Fig. 3 B). This was
in contrast to control hearts, in which ischemia led to the
active propagation of a wave of DJm depolarization that
progressively captured more myocardium (Fig. 3 A).Spatial heterogeneity of DJm in control and LVH
hearts
Because LVH hearts were distinguished by the presence of
spatially adjacent regions of increased and decreasedBiophysical Journal 98(10) 2063–2071DJm, we systematically investigated the degree of DJm
heterogeneity in all control and LVH hearts during the course
of IR injury. Shown in Fig. 4 are representative DJm
contour maps recorded after 7 min of ischemia, and select
DJm traces measured during the course of IR injury (sites
A–H). Clearly, the control hearts exhibited distinct DJm
depolarization during ischemia (Fig. 4 A, sites A–H). In
contrast, LVH was marked by heterogeneous DJm
responses with depolarizing and hyperpolarizing sites
(Fig. 4 B). The extent of DJm heterogeneity was quantified
as the SD of normalized DJm measured from 6400 pixels
during IR injury in control (n ¼ 6) and LVH (n ¼ 11) hearts
(Fig. 5). At all time points during the IR protocol, LVH was
associated with increased DJm heterogeneity compared to
control hearts (Fig. 5 A). In fact, on average, DJm heteroge-
neity was significantly greater during ischemia (by 80.8%,
p < 0.0001) and reperfusion (144.9%, p < 0.001) in LVH
compared to control hearts (Fig. 5 B).
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FIGURE 3 Contour maps showing
the spatiotemporal distribution of DJm
during the course of ischemia (top row)
and reperfusion (bottom row) in repre-
sentative normal (A) and LVH (B)
hearts.
Spatiotemporal Dynamics of DJm in Hypertrophy 2067Enhanced susceptibility of hypertrophied hearts
to reperfusion-mediated arrhythmias
We then investigated potential differences in the propensity
of control and LVH hearts to IR-mediated arrhythmias. We
first calculated the AS values from the continuous ECG
recordings performed in all hearts. Shown in Fig. 6 are
average AS values during ischemia and reperfusion of
control and LVH hearts (top) and representative ECG traces
indicating various levels of arrhythmia complexity, and
reflecting the range of AS values from normal rhythm(AS ¼ 0) to sustained VT/VF (AS ¼ 5) (bottom). Of note,
the average AS values were comparable during ischemia in
both unpaced control and LVH hearts (p ¼ NS). Reperfu-
sion, on the other hand, caused a significant increase in AS
in LVH (p < 0.001) but not control (p ¼ 0.082) hearts.
An additional series of eight hearts (four control and four
LVH) were used to investigate potential differences in the
incidence of complex arrhythmias during ex vivo pacing
(at 4 Hz) and IR injury. Shown in Fig. 7 are representative
volume-conducted ECG traces from control (left) and LVH
(right) hearts. Of interest, steady-state pacing during IRBiophysical Journal 98(10) 2063–2071
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2068 Jin et al.injury revealed the presence of arrhythmias in LVH (2/4) but
not (0/4) control hearts (Fig. 7). Finally, 7 min of ischemia
resulted in rapid shortening of APD90 in LVH but not control
hearts (Fig. 7, bottom).DISCUSSION
Here, we demonstrate the feasibility of measuring the spatio-
temporal dynamics of DJm across the intact organ during IR
injury. The major findings of this study are as follows: 1)
Ischemia generated a wave of active DJm depolarization
across control but not hypertrophied hearts. 2) Complex
areas of DJm depolarization and hyperpolarization coex-
isted across the hypertrophied heart during the entire course
of ischemia. 3) The spatial heterogeneity of DJm was sig-
nificantly greater in LVH than in control hearts during both
ischemia and reperfusion. 4) Hypertrophied hearts were
more sensitive to IR-mediated arrhythmias compared to
control hearts.
Disrupted DJm depolarization in LVH
during IR injury
One of the main contributions of this study is the identifica-
tion of spatiotemporal changes in DJm at a subcellular reso-Biophysical Journal 98(10) 2063–2071lution within the intact organ. We found that DJm, measured
in native myocardium, underwent marked changes during IR
injury. Our finding of DJm depolarization over a 4  4 mm
area during ischemia is consistent with the elegant findings
of Matsumoto-Ida et al. (23), who used two-photon micros-
copy to image a 50 mm region. More recently, Slodzinski
et al. (24) showed heterogeneous DJm depolarization within
the intact guinea pig heart that was associated with increased
reactive oxygen species (ROS) production and depletion of
intracellular glutathione levels. Remarkably, our findings
indicate that reperfusion after 7 min of global no-flow
ischemia in the rat results in complete and sustained recovery
of DJm after reperfusion.
Another major finding of this work is that LVH paradox-
ically disrupts progressive DJm depolarization observed
during the course of ischemia in the control heart. Our find-
ings regarding disrupted DJm polarization in LVH are
consistent with earlier reports indicating that hypertrophy
is associated with marked baseline alterations of DJm at
the cellular level. Previous measurements of DJm in hyper-
trophy have yielded disparate results. Notably, Sharma et al.
(25) demonstrated that LVH in guinea pigs is associated
with a basal reduction of DJm. In contrast, Nagendran
and colleagues (26) reported an increase of DJm in
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Spatiotemporal Dynamics of DJm in Hypertrophy 2069phenylephrine-treated rat neonatal cardiomyocytes, adult
rat hearts from animals with monocrotaline induced pulmo-
nary hypertension, and human tissue samples from patients
with right ventricular hypertrophy undergoing cardiac sur-
gery (26). Both groups compared the total fluorescence of
mitochondrial dyes (TMRM or JC1) during steady state,
whereas our approach allowed the measurement of dynamic
spatiotemporal changes in DJm relative to baseline during
IR injury. It is worth noting that in the study by Sharma
et al. (25), animals were examined at a more advanced stage
of the disease (10 weeks after aortic banding), which
reflected the transition point from cardiac hypertrophy to
heart failure.
Nagendran and colleagues (26) linked the increase in
DJm to changes in pyruvate metabolism, whereas Sharma
et al. (25) emphasized the activation of apoptotic pathwaysthrough ROS. A major consequence of ROS accumulation
involves alterations in the function of mitochondrial ion chan-
nels, such as the permeability transition pore (PTP) and the
inner membrane mitochondrial ion channel (IMAC). Aon
and colleagues (27) elegantly showed that the glutathione
redox couple (GSH/GSSG) of the cardiac cell governs the
sequential opening of these channels, with reversible IMAC
activation occuring before irreversible PTP opening. Of
interest, PTP opening during calcium stress is more likely in
hypertrophied compared to control hearts (28). Others have
described changes in ion fluxes that may protect against the
loss of DJm. The activity of the newly discovered mitochon-
drial calcium channels (mCa1 and mCa2) was shown to be
significantly reduced in end-stage human heart failure, result-
ing in lower mitochondrial calcium influx and stabilizedDJm
(29). Moreover, the development of hypertrophy is associated
with marked changes in the expression of uncouplingBiophysical Journal 98(10) 2063–2071
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2070 Jin et al.proteins, which are known to regulate DJm and ROS gener-
ation. In fact, our finding ofDJm hyperpolarization in LVH is
consistent with the down-regulation of uncoupling proteins
that has been observed in animal models and humans with
hypertrophy (30).
In this study, we demonstrate how mitochondria within
their native environment can react differentially to the
same acute stressor (IR injury) in chronically diseased
compared to control hearts. The altered polarization patterns
of DJm in hypertrophy could represent an adaptive mecha-
nism with beneficial or deleterious physiological conse-
quences. Both elevations and depressions of DJm can lead
to increased ROS production (31). An increase in DJm,
for example, may provide a protective mechanism against
apoptosis, a process that is considered to be central in the
transition from compensated hypertrophy to end-stage heart
failure. On the other hand, increased DJm may also interfere
with mitochondrial substrate transport and respiration, and
thus may underlie some of the adverse metabolic remodeling
observed in hypertrophy.Biophysical Journal 98(10) 2063–2071Increased DJm heterogeneity in LVH
In addition to allowing the measurement of average changes
in DJm, our technique is also well suited for detailed inves-
tigations of the spatiotemporal dynamics of DJm across
a relatively large (4 4 mm) region of the epicardial surface.
We observed a spatially complex distribution of polarized
and depolarized regions of DJm in hypertrophied hearts
that were not present in control hearts during ischemia.
Since the mitochondrial function of individual cells is
highly influenced by network properties, it is critical to
investigate subcellular mitochondrial function within the
milieu of the intact heart. Specifically, our findings indicate
a heterogeneous metabolic substrate across the heart during
IR injury. These heterogeneities may ultimately modulate
myocardial excitability and contribute to the formation of
zones of conduction block by heterogeneous activation of
surface ATP-sensitive potassium channels (11,32). As
such, these metabolic heterogeneities are consistent with
the notion of metabolic sink/block recently suggested by
Akar and colleagues (11).Heightened susceptibility of LVH hearts to
reperfusion-mediated arrhythmias
Sustained arrhythmias caused by oxidative stress associated
with IR injury are known to occur during early reperfusion.
Indeed, we found that spontaneously arising arrhythmic
events (quantified by an AS index) were significantly greater
during reperfusion compared to ischemia in LVH but not
control hearts, implicating oxidative stress in the mechanism
of these arrhythmias. Moreover, our finding that complex
arrhythmias (VT/VF) in paced hearts were exclusively
present in LVH but not control hearts undergoing IR injury
further highlights the susceptibility of LVH hearts to arrhyth-
mias, even when HR is controlled. Although hypertrophy is
characterized by complex structural, mechanical, and elec-
trophysiological alterations that render the heart more
vulnerable to arrhythmias (15), our findings highlight a
potentially critical role for metabolic remodeling in general,
and altered DJm properties in particular, in the mechanism
of these arrhythmias.
Finally, we previously showed that partial blockade of
IMAC, which in isolated myocytes can stabilize DJm, is
an effective tool for preventing reperfusion-mediated VT/
VF in guinea pigs (11). Our current findings indicate that
increased DJm during ischemia in LVH promotes rather
than prevents arrhythmias upon reperfusion. These appar-
ently contradictory findings suggest that there might indeed
be a delicate balance of DJm changes that can either
promote or prevent arrhythmias. Of interest, the highest
concentration of IMAC blocker (40-Cl-DZP) in our previous
study (100 mM), which effectively prevented the formation
of inexcitability (electrical silence) throughout the entire
ischemic period, was not effective in suppressing
Spatiotemporal Dynamics of DJm in Hypertrophy 2071reperfusion-mediated arrhythmias, in contrast to lower
concentrations (64 mM) (11). This is consistent with our
present findings that complete abrogation of DJm depolar-
ization during metabolic stress associated with ischemic
injury is indeed pro-arrhythmic.
Limitations
Ischemic injury results in highly complex electrophysiolog-
ical changes that ultimately render the heart prone to
arrhythmias. In this work, we focused on a key metric of mito-
chondrial function (DJm) that drives the electron transport
chain by setting the electromotive force. In humans and
animal models, IR-related arrhythmias are dependent on
multifactorial mechanisms such as changes in ion gradients
(hyperkalemia, sodium and calcium overload), acidosis, and
gap junction uncoupling. Therefore, one should not expect
that a single metric of cardiac function will fully predict
arrhythmias in this setting. However, our present findings
strongly implicate mitochondrial dysfunction in general,
and disrupted DJm kinetics during ischemia in particular,
as an important mechanism of arrhythmias in LVH.
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